Article Information
History
- August 7, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Rhea J Longley1,2,
- Michael T White3,
- Jessica Brewster1,
- Zoe SJ Liu1,2,
- Caitlin Bourke1,2,
- Eizo Takashima4,
- Matthias Harbers5,
- Wai-Hong Tham2,6,
- Julie Healer2,6,
- Chetan E Chitnis7,
- Wuelton Monteiro8,9,
- Marcus Lacerda10,
- Jetsumon Sattabongkot11,
- Takafumi Tsuboi4 and
- Ivo Mueller1,2,3,*
- 1Population Health and Immunity Division, The Walter and Eliza Hall Institute of Medical Research, Parkville 3052, Australia
- 2Department of Medical Biology, University of Melbourne, Parkville 3052, Australia
- 3Malaria Parasites and Hosts Unit, Department of Parasites and Insect Vectors, Institut Pasteur, Paris, France
- 4Division of Malaria Research, Proteo-Science Center, Ehime University, Matsuyama, Japan
- 5CellFree Sciences Co., Ltd., RIKEN Center for Integrative Medical Sciences, Yokohama, Japan
- 6Infection and Immunity Division, The Walter and Eliza Hall Institute of Medical Research, Parkville 3052, Australia
- 7Malaria Parasite Biology and Vaccines, Department of Parasites and Insect Vectors, Institut Pasteur, Paris, France
- 8Fundacão de Medicina Tropical Dr. Heitor Vieira Dourado, Manaus, Brazil
- 9Universidade do Estado do Amazonas, Manaus, Brazil
- 10Instituto Leônicas & Maria Deane (Fiocruz), Manaus, Brazil
- 11Mahidol Vivax Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok 10400, Thailand
- ↵*
Corresponding author:
Ivo Mueller, mueller{at}wehi.edu.au, +61 3 9345 2936
Posted August 07, 2020.
IgG antibody responses are preferential compared to IgM for use as serological markers for detecting recent exposure to Plasmodium vivax infection
